Financial results - SALIX PHARM SRL

Financial Summary - Salix Pharm Srl
Unique identification code: 10354331
Registration number: J26/132/1998
Nace: 8299
Sales - Ron
-
Net Profit - Ron
-4.676
Employee
The most important financial indicators for the company Salix Pharm Srl - Unique Identification Number 10354331: sales in 2023 was - euro, registering a net profit of -4.676 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Alte activitati de servicii suport pentru intreprinderi n.c.a. having the NACE code 8299.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Salix Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 252.526 250.225 231.925 135.165 65.883 71.606 48.185 0 0 0
Total Income - EUR 253.783 250.268 232.060 158.397 65.884 71.607 214.050 1.565 34 0
Total Expenses - EUR 249.520 254.378 228.374 166.352 100.500 102.935 82.793 4.661 4.495 4.676
Gross Profit/Loss - EUR 4.263 -4.110 3.686 -7.954 -34.616 -31.328 131.258 -3.096 -4.461 -4.676
Net Profit/Loss - EUR 2.961 -4.562 2.712 -9.498 -35.278 -32.046 129.071 -3.096 -4.461 -4.676
Employees 7 7 5 4 4 3 3 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Salix Pharm Srl

Rating financiar

Financial Rating -
Salix Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Salix Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Salix Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Salix Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Salix Pharm Srl - CUI 10354331

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 48.225 46.870 43.613 36.155 29.329 28.868 26.957 24.014 22.750 21.347
Current Assets 82.937 75.586 53.150 39.114 32.220 27.675 102.073 2.673 1.214 1.700
Inventories 40.870 44.630 33.717 19.920 19.698 17.436 0 0 0 0
Receivables 35.796 23.690 11.055 4.222 9.284 7.189 242 821 914 1.339
Cash 6.272 7.265 8.377 14.971 3.237 3.051 101.831 1.852 300 361
Shareholders Funds 58.355 48.738 40.053 28.078 -7.716 -39.612 90.209 26.694 22.316 17.572
Social Capital 45 45 45 88 86 84 83 81 81 81
Debts 73.301 74.058 57.324 47.716 69.536 96.720 38.820 0 1.649 5.475
Income in Advance 0 300 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8299 - 8299"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.700 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.339 euro and cash availability of 361 euro.
The company's Equity was valued at 17.572 euro, while total Liabilities amounted to 5.475 euro. Equity decreased by -4.676 euro, from 22.316 euro in 2022, to 17.572 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Salix Pharm Srl

Comments - Salix Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.